Randomized, Open-Label, Crossover Studies Evaluating the Effect of Food and Liquid Formulation on the Pharmacokinetics of the Novel Focal Adhesion Kinase (FAK) Inhibitor BI 853520

BACKGROUND: BI 853520 is a potent inhibitor of focal adhesion kinase and is currently under clinical development for the treatment of non-hematological malignancies. OBJECTIVE: The objective of this study was to evaluate the effect of food and liquid dispersion on the pharmacokinetics of BI 853520 i...

Descripción completa

Detalles Bibliográficos
Autores principales: Verheijen, Remy B., van der Biessen, Diane A. J., Hotte, Sebastien J., Siu, Lillian L., Spreafico, Anna, de Jonge, Maja J. A., Pronk, Linda C., De Vos, Filip Y. F. L., Schnell, David, Hirte, Hal W., Steeghs, Neeltje, Lolkema, Martijn P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407750/
https://www.ncbi.nlm.nih.gov/pubmed/30742245
http://dx.doi.org/10.1007/s11523-018-00618-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407750/
https://www.ncbi.nlm.nih.gov/pubmed/30742245
http://dx.doi.org/10.1007/s11523-018-00618-0

Ejemplares similares